ARCHIVES

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

This article is from The Cancer Letter archive.

Vol. 16 No. 42 | November 2, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

Aventis, MediGene In Pact For Development Of Vaccine.

February 25, 2000

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991

In Brief: Hellman to Leave Memorial This Fall For Position As Dean, Vice President at Univ. Of Chicago

April 8, 1988

Youth Smoking Begins To Decline, NCI Says

April 5, 2002

Tobacco Interests Contribute a Portion Of the $109 Million Raised by Stand Up To Cancer

September 12, 2014